Bluejay Diagnostics, Inc. is a medical diagnostics company based in Acton, MA, dedicated to improving patient outcomes through the development of cost-effective, rapid, near-patient products for triage, diagnosis, and monitoring of disease progression. Their leading product candidate, SymphonyTM, is a near-patient biomarker detection platform that combines the reliable ELISA methodology with modern advances in nanotechnology to provide fast, simple, safe, and highly sensitive biomarker detection.
Bluejay Diagnostics' Symphony is an automated diagnostic system that utilizes a sample-to-result format, eliminating the need for highly trained laboratory technicians and reducing test complexity. Their platform is designed to enable simple, rapid, and cost-effective analysis from a single clinical sample, making it accessible to LTACs, hospitals, and clinics that traditionally could not afford more expensive or complex diagnostic testing platforms. With a focus on serving unmet needs in the blood and hospital markets, Bluejay Diagnostics is committed to modernizing laboratory testing and providing better patient testing at an affordable cost in time-sensitive, life-threatening situations.
Generated from the website